AstraZeneca UK Limited

Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003

Patient Information Leaflet last updated on the eMC: 17/08/2009
PIL Xylocaine 1% and 2% with Adrenaline

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/08/2009 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 01/04/2009 and displayed until 17/08/2009
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to Further Information section
Updated on 13/08/2008 and displayed until 01/04/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 14/02/2005 and displayed until 13/08/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   adrenaline
   lidocaine hydrochloride